Establishing secure connection…Loading editor…Preparing document…

Beta Tester Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

BETA TESTER AGREEMENT

This Beta Tester Agreement (the "Agreement") is entered into as of by and between Company Name: , a legal entity organized at Company Address: (\"Company\"), and Tester Name: , residing at Tester Address: (\"Tester\").

RECITALS

WHEREAS, Company is developing certain software, hardware, firmware, services, and related materials identified as: (the "Product"); and

WHEREAS, Company desires to engage Tester to test the Product prior to general commercial release under the terms and conditions set forth herein; and

WHEREAS, Tester agrees to perform testing and provide feedback under confidentiality and assignment obligations designed to protect Company’s proprietary interests.

NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties agree as follows:

1. DEFINITIONS

1.1 "Confidential Information" means non-public information disclosed by Company to Tester in any form, including product plans, designs, specifications, prototypes, business and marketing plans, source code, test results, and any notes, analyses, or materials derived therefrom.

1.2 "Feedback" means any suggestions, reports, bug reports, improvements, or other information provided by Tester to Company relating to the Product.

2. GRANT OF ACCESS

2.1 Company hereby grants Tester a limited, non-exclusive, non-transferable, revocable license to access and use the Product solely for internal testing and evaluation during the Beta Period set forth below and solely in accordance with this Agreement.

2.2 Beta Period begins on and ends on unless earlier terminated as provided herein.

3. TESTER RESPONSIBILITIES

3.1 Tester shall use reasonable efforts to test the Product, reproduce issues, and provide timely and accurate Feedback through the reporting channels designated by Company. Tester shall record and report all material defects and shall cooperate with Company technicians to reproduce and diagnose issues.

3.2 Tester shall not make the Product available to third parties, use the Product for any commercial purpose, or disclose the Product to any person except individuals who are bound by substantially similar confidentiality obligations and solely to the extent necessary to perform testing.

4. CONFIDENTIALITY

4.1 Tester acknowledges that Confidential Information is the exclusive property of Company. Tester will hold Confidential Information in strict confidence, will not disclose it to third parties, and will not use it except to perform the obligations in this Agreement.

4.2 The confidentiality obligations shall not apply to information that: (a) is publicly known through no breach by Tester; (b) was rightfully known by Tester prior to disclosure; or (c) is independently developed without use of Confidential Information. Tester bears the burden of proving any exception applies.

5. FEEDBACK AND ASSIGNMENT

5.1 Tester hereby assigns to Company all right, title and interest, including intellectual property rights, in and to all Feedback. To the extent any moral rights or other rights cannot be assigned, Tester hereby irrevocably waives such rights and agrees to execute documents reasonably requested to effectuate the assignment.

5.2 Tester acknowledges that no consideration beyond that expressly set forth in this Agreement is owed for Feedback unless a separate written agreement is executed by the parties.

6. DATA, PRIVACY AND SECURITY

6.1 Tester may provide or generate data in the course of testing. Tester grants Company a perpetual, worldwide, royalty-free license to use such data for any purpose including product development and analytics, provided that Company will handle any personal data in accordance with applicable law.

6.2 Tester shall follow reasonable security practices and promptly notify Company of any unauthorized access or disclosure of Confidential Information or Test Data.

7. TERM AND TERMINATION

7.1 This Agreement commences on the Effective Date and continues through the end of the Beta Period unless earlier terminated in accordance with this Section. Either party may terminate immediately for material breach by written notice to the other party.

7.2 Upon expiration or termination, Tester shall cease use of the Product and, at Company’s election, return or destroy all Confidential Information and certify destruction in writing.

8. WARRANTY DISCLAIMER

8.1 THE PRODUCT IS PROVIDED "AS IS" FOR TESTING PURPOSES ONLY. COMPANY DISCLAIMS ALL WARRANTIES, WHETHER EXPRESS, IMPLIED, STATUTORY OR OTHERWISE, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT.

9. LIMITATION OF LIABILITY

9.1 IN NO EVENT SHALL COMPANY BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, PUNITIVE OR CONSEQUENTIAL DAMAGES ARISING OUT OF THIS AGREEMENT OR TESTING OF THE PRODUCT, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. COMPANY'S AGGREGATE LIABILITY SHALL NOT EXCEED THE TOTAL AMOUNT, IF ANY, PAID BY COMPANY TO TESTER UNDER THIS AGREEMENT.

10. INDEMNIFICATION

10.1 Tester shall defend, indemnify and hold harmless Company and its officers, directors and affiliates from and against any third-party claims arising out of Tester’s breach of this Agreement, negligence, willful misconduct, or unauthorized use or distribution of the Product.

11. PUBLICITY

11.1 Tester shall not issue any press release, public statement, or marketing material referring to Company or the Product without Company’s prior written consent. Company may identify Tester as a beta participant unless Tester objects in writing.

12. NOTICES

Notices shall be in writing and delivered by hand, certified mail, or nationally recognized courier service and shall be effective upon receipt.

13. AMENDMENTS; WAIVER

13.1 No amendment or waiver of any provision of this Agreement shall be effective unless in a written instrument signed by both parties. The failure by either party to enforce any right shall not constitute a waiver of future enforcement of that or any other right.

14. GOVERNING LAW

This Agreement shall be governed by and construed in accordance with the laws of the state of without regard to principles of conflicts of law.

15. ENTIRE AGREEMENT; SEVERABILITY

15.1 This Agreement, together with any written attachments, constitutes the entire agreement between the parties with respect to the subject matter and supersedes all prior and contemporaneous agreements, representations and understandings.

15.2 If any provision of this Agreement is held invalid or unenforceable, the remaining provisions shall remain in full force and effect and the parties shall negotiate in good faith a substitute provision that achieves the parties’ original intent as closely as possible.

16. COUNTERPARTS

16.1 This Agreement may be executed in counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument. Signatures delivered by electronic means shall be binding.

ADDITIONAL TERMS

Individual Corporation Other

ACKNOWLEDGMENT

Tester acknowledges that the Product is in pre-release form and may contain defects. Tester accepts all risks associated with use of the Product and will not rely on the Product for critical operations. Tester confirms authority to enter into this Agreement and that all information provided to Company is true and complete.

Company:

By:

Date:

Tester:

By:

Date:

Enter text✕

What a Beta Tester Agreement Covers

A Beta Tester Agreement is a written contract between a product owner and an individual or organization invited to test pre-release software or hardware. It defines the scope of testing, confidentiality obligations, ownership of feedback and intellectual property, permitted data use, term and termination conditions, and any compensation or reimbursement. The agreement also allocates risk by limiting warranties and liability and by specifying dispute resolution and governing law. When executed electronically under ESIGN and state UETA statutes, it creates a binding record if parties demonstrate intent, consent, attribution, and retention.

Why use a Beta Tester Agreement

A clear agreement protects product IP, sets expectations for feedback quality and timing, limits liability, and describes data handling. It reduces later disputes about ownership of improvements and ensures testers understand confidentiality and permitted disclosures under applicable privacy rules.

Why use a Beta Tester Agreement

Who typically signs a Beta Tester Agreement

These agreements are used across organizations of different sizes; the signer profile affects required clauses and authentication measures.

  • Small and midsize software vendors running closed betas to validate features before public release, requiring simple confidentiality and feedback ownership terms.
  • Enterprise product teams that run structured pilot programs and need robust data handling, indemnity, and audit-capable approval workflows.
  • Independent developers and freelancers engaged for targeted testing who need clear IP assignment and payment or credit terms to avoid later disputes.

Match the agreement complexity to the program: simple tester releases for public betas, fuller IP and privacy protections for closed or regulated-product pilots.

Core clauses to include in a professional agreement

A concise Beta Tester Agreement groups essential clauses so expectations and rights are explicit for both parties.

Parties

Clear legal names and contact details for the company and tester, identifying whether the signer acts personally or on behalf of an organization.

Scope

Precise description of the product, build/version, testing activities required, geographic or platform limits, and acceptance criteria for delivered feedback.

Confidentiality

Non‑disclosure terms specifying what information is confidential, permitted disclosures, duration, and remedies for breach.

Feedback & IP

Assignment or license terms for tester feedback, bug reports, and improvements; define whether feedback becomes company property and any retained rights.

Data Handling

Data collection, permitted uses, security requirements, and any healthcare or student data handling addenda required by law (e.g., HIPAA, FERPA).

Liability

Warranty disclaimers, indemnities, limitation of liability caps, and carve-outs for intentional misconduct or gross negligence.

Step-by-step: completing and executing the agreement

Follow these sequential steps to prepare, receive, and archive a signed Beta Tester Agreement.

  • 01
    Draft: Prepare a clear draft with required attachments.
  • 02
    Review: Legal or product teams review scope, IP, and privacy terms.
  • 03
    Send for signature: Use an e-signature workflow with authentication and consent steps.
  • 04
    Archive: Store the executed copy with the audit trail and related evidence.

Typical online configuration for e-execution

Common workflow settings simplify signing while preserving legal validity and auditability.

Field Configuration
Signer Authentication Email plus SMS code
Signature Fields Signature, date, initials
Conditional Fields Show payment clause if paid beta selected
Audit Trail Capture IP, timestamp, and action log

Platforms and formats for digital completion

Choose a platform that supports standard file types, signer authentication, and a verifiable audit trail for legal enforceability.

  • File Formats: PDF, DOCX supported
  • Integrations: Salesforce, NetSuite, Google Workspace
  • Authentication: Email, SMS, KBA options

Ensure the chosen service can export a tamper-evident signed PDF with an audit certificate and can meet any industry-specific compliance such as HIPAA or 21 CFR Part 11 when required.

Where to send and how signatures are captured

A standard electronic signing flow reduces friction and preserves evidence required under ESIGN and state UETA statutes.

  • Upload Document: Sender uploads final agreement file.
  • Place Fields: Add signature, date, and authentication fields.
  • Invite Signer: Signer receives email or secure link.
  • Store Signed Copy: System saves signed PDF and audit trail.

Key timing considerations for a beta program

Define and communicate deadlines clearly so tester obligations and company review windows are enforceable.

Execution Before Access:

Agreement executed before granting beta credentials or downloads.

Feedback Windows:

Specify required feedback delivery within 7–30 days of assigned test tasks.

Confidentiality Term:

State the confidentiality period (commonly 2–5 years) after termination.

Post-Termination Returns:

Require return or deletion of company materials within 10 business days.

Recordkeeping:

Retain executed agreements and audit trails per retention policy.

Security and compliance considerations

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest
Audit Trail: Timestamped actions and IP addresses recorded
Certifications: SOC 2 Type II and ISO 27001 available
HIPAA BAA: BAA available for covered entity needs
21 CFR Part 11: Compliant options for FDA-regulated records
Access Controls: Role-based access and SSO/SAML support

Legal and operational risks to watch

Breach of NDA: Monetary damages and injunction risk
Invalid E-signature: Improper consent may void signature
IP Dispute: Unclear assignment can trigger litigation
Privacy Violation: HIPAA or state laws may impose fines
Late Feedback: Delays can undermine product schedules
Indemnity Exposure: Broad indemnities increase company risk

Common preparation mistakes to avoid

  • Vague scope statements that fail to define which features or builds are covered, creating disagreement about what the tester was asked to evaluate.
  • Missing or weak IP language that leaves feedback ownership ambiguous and can result in costly disputes over rights to improvements.
  • Insufficient data handling terms when personal or health information is collected, which can cause regulatory noncompliance and liability.
  • Using initials or informal acknowledgements where full, dated signatures are required, reducing evidence of consent and intent.

Practical drafting and execution advice

Apply these practices to reduce ambiguity and preserve enforceability while respecting tester usability.

Define testing scope precisely
List product version, features, platforms, tasks, and success criteria. Attach a test matrix or task list as an exhibit to avoid later disputes about completeness or required coverage.
Use clear IP and feedback language
State whether feedback is assigned or licensed and whether any preexisting tester IP is excluded. Consider a narrow assignment to reported defects and improvements only.
Tailor data protections
If the test collects PII or PHI, include encryption, access limits, retention schedules, and a HIPAA BAA where required. Specify incident reporting timelines.
Preserve audit evidence
Require an e-signature solution that captures timestamps, IP addresses, signer authentication, and an exportable certificate of completion to support enforceability under ESIGN and UETA.

Representative scenarios showing practical uses

Two typical examples illustrate how agreements vary by product risk and data sensitivity.

SaaS product beta

A mid‑stage SaaS company runs a closed beta on a new dashboard to gather usability feedback and bug reports.

  • Testers provide structured reports with screenshots and log files to reproduce issues.
  • Agreement focuses on feedback assignment, short confidentiality term, and limited liability while allowing testers to continue developing unrelated features independently.

Medical device pilot

A regulated device maker engages clinicians to test a companion app that handles patient data.

  • Testers must follow controlled workflows and submit de‑identified logs where possible.
  • Agreement includes HIPAA‑compliant data handling, a BAA, explicit reporting timelines for adverse events, and stricter retention and audit requirements.

Comparing common eSignature vendors for executing Beta Tester Agreements

Vendor features and pricing models influence authentication, audit, and compliance capabilities for executing Beta Tester Agreements electronically.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies Varies Varies Varies
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Who can sign on behalf of each party

Tester — Individual

An individual tester signs in a personal capacity when they are not representing a business. The signature binds that person to confidentiality, feedback assignment, and data handling obligations; collections of personal data should be limited and consent documented for compliance.

Company Authorized Rep

A company should designate an authorized representative (title and authority specified) to sign agreements. That signer must have authority to bind the entity for IP assignment, indemnities, and payment obligations to ensure contractual enforceability.

How to update or amend an executed agreement

Use a controlled amendment process to keep changes clear and legally binding.

01

Identify Change:

Document the specific clause or schedule that requires revision and the reason for the change.
02

Draft Amendment:

Prepare a one‑page amendment or redline showing exact wording changes and effective date.
03

Obtain Approval:

Have legal review and obtain internal signoff before presenting to the tester.
04

Execute Amendment:

Have both parties sign the amendment using the same e-signature process as the original.
05

Attach to File:

Store amendment with the original agreement and maintain a combined audit trail.
06

Communicate:

Notify relevant teams (product, QA, legal) and update access or tasks as needed.

Frequently asked questions about Beta Tester Agreements

Answers to common execution and enforceability questions for Beta Tester Agreements, with references to applicable U.S. statutes where helpful.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users